Procurement for pegloticase 8MG/ML INJ soln
Ended Awarded
- Contract number
- 36C26222N0412
- Awardee
-
Horizon Therapeutics Usa, Inc. UEI SK1UK7S74GB3
- Awarding agency
-
Veterans Integrated Service Network 22
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $281,498
Award facts
- Contract value 100% obligated
- $281,498.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- La Vergne, TN 37086, USA
Award details come from SAM.gov/FPDS.
About this award
This is a firm fixed-price contract awarded by the Veterans Integrated Service Network 22 (VISN 22) of the U.S. Department of Veterans Affairs (VA) to Horizon Therapeutics USA Inc. for the procurement of the drug Pegloticase 8mg/mL injection solution. The contract has a ceiling value of $281,498.24 and a completion date of September 30, 2022. It was awarded on March 16, 2022 and is a call against Horizon's existing Blanket Purchase Agreement (BPA) under the VA's Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). Horizon Therapeutics USA Inc. is a global biotechnology company that specializes in developing and commercializing medicines for rare, autoimmune, and severe inflammatory diseases, and has a strong presence in providing specialty pharmaceuticals and orphan drugs to the VA. This contract does not have a set-aside designation.
Quick answers
Who was awarded contract 36C26222N0412?
36C26222N0412 was awarded to Horizon Therapeutics Usa, Inc. by Veterans Integrated Service Network 22 (Veterans Health Administration) on March 16, 2022.
How much is contract 36C26222N0412 worth?
The government has obligated $281,498 on 36C26222N0412.
Is contract 36C26222N0412 an order under another contract?
Yes. 36C26222N0412 is a BPA call under 36F79719D0224-36E79719A0032, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26222N0412 competed?
The extent of competition for 36C26222N0412 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award